250 related articles for article (PubMed ID: 32633664)
21. Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder.
Haffajee RL; Lin LA; Bohnert ASB; Goldstick JE
JAMA Netw Open; 2019 Jun; 2(6):e196373. PubMed ID: 31251376
[TBL] [Abstract][Full Text] [Related]
22. Multiscale dimensions of county-level disparities in opioid use disorder rates among older Medicare beneficiaries.
Yang TC; Shoff C; Choi SE; Sun F
Front Public Health; 2022; 10():993507. PubMed ID: 36225787
[TBL] [Abstract][Full Text] [Related]
23. Utilization of treatment by Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB
Drug Alcohol Depend; 2020 Dec; 217():108261. PubMed ID: 32979735
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of Hospitalized Adults with Opioid Use Disorder in the United States: Nationwide Inpatient Sample.
Alemu BT; Olayinka O; Martin BC
Pain Physician; 2021 Aug; 24(5):327-334. PubMed ID: 34323434
[TBL] [Abstract][Full Text] [Related]
25. Age of initiation, psychopathology, and other substance use are associated with time to use disorder diagnosis in persons using opioids nonmedically.
Schepis TS; Hakes JK
Subst Abus; 2017; 38(4):407-413. PubMed ID: 28723266
[TBL] [Abstract][Full Text] [Related]
26. Associations of alcohol use disorder, cannabis use disorder, and nicotine dependence with concurrent opioid use disorder in U.S. adults.
Harton MR; Adams ZW; Parker MA
Exp Clin Psychopharmacol; 2023 Dec; 31(6):998-1004. PubMed ID: 37166911
[TBL] [Abstract][Full Text] [Related]
27. Opioid Use Disorder Among Ohio's Medicaid Population: Prevalence Estimates From 19 Counties Using a Multiplier Method.
Doogan NJ; Mack A; Wang J; Crane D; Jackson R; Applegate M; Villani J; Chandler R; Barocas JA
Am J Epidemiol; 2022 Nov; 191(12):2098-2108. PubMed ID: 36004683
[TBL] [Abstract][Full Text] [Related]
28. A comprehensive multivariate model of biopsychosocial factors associated with opioid misuse and use disorder in a 2017-2018 United States national survey.
Montiel Ishino FA; McNab PR; Gilreath T; Salmeron B; Williams F
BMC Public Health; 2020 Nov; 20(1):1740. PubMed ID: 33208132
[TBL] [Abstract][Full Text] [Related]
29. Comparison of opioid use disorder among male veterans and non-veterans: Disorder rates, socio-demographics, co-morbidities, and quality of life.
Rhee TG; Rosenheck RA
Am J Addict; 2019 Feb; 28(2):92-100. PubMed ID: 30664282
[TBL] [Abstract][Full Text] [Related]
30. Association of current and past opioid use disorders with health-related quality of life and employment among US adults.
Rhee TG; Rosenheck RA
Drug Alcohol Depend; 2019 Jun; 199():122-128. PubMed ID: 31039486
[TBL] [Abstract][Full Text] [Related]
31. Opioid Use Disorder Stigma, Discrimination, and Policy Attitudes in a National Sample of U.S. Young Adults.
Adams ZW; Taylor BG; Flanagan E; Kwon E; Johnson-Kwochka AV; Elkington KS; Becan JE; Aalsma MC
J Adolesc Health; 2021 Aug; 69(2):321-328. PubMed ID: 33579622
[TBL] [Abstract][Full Text] [Related]
32. Opioid-related US hospital discharges by type, 1993-2016.
Peterson C; Xu L; Florence C; Mack KA
J Subst Abuse Treat; 2019 Aug; 103():9-13. PubMed ID: 31229192
[TBL] [Abstract][Full Text] [Related]
33. Self-Reported Treatment Need and Barriers to Care for Adults With Opioid Use Disorder: The US National Survey on Drug Use and Health, 2015 to 2019.
Saini J; Johnson B; Qato DM
Am J Public Health; 2022 Feb; 112(2):284-295. PubMed ID: 35080954
[No Abstract] [Full Text] [Related]
34. Racial equity in linkage to inpatient opioid use disorder treatment in patients that received emergency care.
Faiz J; Bernstein E; Dugas JN; Schechter-Perkins EM; Nentwich L; Nelson KP; Cleveland Manchanda EC; Young L; Pare JR
Am J Emerg Med; 2022 Apr; 54():221-227. PubMed ID: 35180668
[TBL] [Abstract][Full Text] [Related]
35. Posttraumatic stress disorder and chronic pain are associated with opioid use disorder: Results from a 2012-2013 American nationally representative survey.
Bilevicius E; Sommer JL; Asmundson GJG; El-Gabalawy R
Drug Alcohol Depend; 2018 Jul; 188():119-125. PubMed ID: 29775955
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal associations between age 20 problematic substance use and opioid use disorder incidence at age 30 - findings from an urban cohort.
Thrul J; Rabinowitz JA; Reboussin BA; Maher BS; Anthony JC; Ialongo NS
J Psychiatr Res; 2023 Apr; 160():1-7. PubMed ID: 36764195
[TBL] [Abstract][Full Text] [Related]
37. Opioid analgesic use and its sequelae: Opioid and other substance use disorders.
Rhee TG; Rosenheck RA
Early Interv Psychiatry; 2021 Aug; 15(4):975-982. PubMed ID: 32930517
[TBL] [Abstract][Full Text] [Related]
38. Responding to the US opioid crisis: leveraging analytics to support decision making.
Brandeau ML
Health Care Manag Sci; 2023 Dec; 26(4):599-603. PubMed ID: 37804456
[TBL] [Abstract][Full Text] [Related]
39. Correlates of death during outpatient treatment for opioid use disorder: A national study.
Goldman JE; Samuels EA; Rich JD; Marshall BDL
J Subst Abuse Treat; 2020 May; 112():76-85. PubMed ID: 32199549
[TBL] [Abstract][Full Text] [Related]
40. Prescription opioid misuse motive latent classes: outcomes from a nationally representative US sample.
Schepis TS; De Nadai AS; Ford JA; McCabe SE
Epidemiol Psychiatr Sci; 2020 Jan; 29():e97. PubMed ID: 31992376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
